brochure-global alzheimers drug market trends opportunities and forecasts (2015-2020f)

(c) AZOTH AnalyticsDecember 2015

Global Alzheimer’s Drug Market: Trends, Opportunities and

Forecasts (2015-2020)

1

(c) AZOTH Analytics

Table of Content

Figure No. Title Page No.

1 Research Methodology

2 Alzheimer’s Disease Market Overview

3 Global Alzheimer’s Disease Market Outlook

4 Global Alzheimer’s Disease Market

4.1 By Therapeutics

4.2 By Diagnostics and Biomarkers

4.3 By Imaging Sector

4.4 By Disease Modifying Therapeutics

5 Global Alzheimer’s Disease Market Outlook-By Demographic (Age-Group)

6 Global Alzheimer’s Disease Market Outlook-By Drug

6 Global Alzheimer’s Disease Market Outlook-By Region

7 United States Alzheimer’s Disease Market Outlook

7.1 United States Dementia Market Outlook

8 Global Dementia Disease Market Outlook

9 Global Dementia Disease Market Outlook,

9.1 By Regional Break-Up

9.1.1 Asia-Pacific Dementia Market Outlook

9.1 By Countries

9.2.2 Low Income Country -wise Break up

9.2.3 Top Ten Country-wise Break-Up

2

(c) AZOTH Analytics

Table of Content

FigureNo.

Title Page No.

9.3 Australia Dementia Market Outlook

9.4 UK Dementia Market Outlook

10 Market Dynamics

10.1 Drivers

10.2 Challenges

11 Market Trends & Developments

12 Competitive Landscape

12.2 Sales Comparatives, Top 5 Companies

12.3 EBITDA Comparatives, Top 5 Companies

12.4 EBIT Comparatives, Top 5 Companies

12.5 PBT Comparatives, Top 5 Companies

12.6 PAT Comparatives, Top 5 Companies

12.7 Current Ratio Comparatives, Top 5 Companies

12 Company Profiling

Pfizer Inc.

Novartis International AG

Axovant Sciences Ltd.

Acadia Pharmaceuticals

Biotie Therapies

3

(c) AZOTH Analytics

Table of Content

FigureNo.

Title Page No.

12.8 Profit Margin Ratio Comparatives, Top 5 Companies

12.9 Debt-Equity Ratio Comparatives, Top 5 Companies

13 About Us & Disclaimer

4

(c) AZOTH Analytics

List of Figures


Figure 1: Global Alzheimer’s Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F

Figure 2: Global Alzheimer’s Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F

Figure 3: Global Alzheimer’s Market share, By Therapeutics

Figure 4: Global Alzheimer’s Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)

Figure 5: Global Alzheimer’s Disease Market, By Imaging Sector, By Value (USD Million)x`

Figure 6: Global Alzheimer’s Disease Market by Disease Modifying Therapeutics Market Size ,By Value (USDMillion)

Figure 7: Global Alzheimer’s Disease Market, By Demographics, By Age < 65, By Volume (Number of patients inmillion),2010-2020F

Figure 8: Global Alzheimer’s Disease Market, By Demographics, By Age > 65, By Volume (Number of patients inmillion),2010-2020F

Figure 9: Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patientsin Million) 2010-2020F

Figure 10: United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of PatientsIn Million) 2010-2020F

Figure 11: Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14

Figure 12: U.S. Alzheimer’s Drug RTV-101 Market , By Value & Penetration Rate; 2019-2027 (USD Million)

Figure 13: U.S. Alzheimer’s Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)

Figure 14: U.S. Annual Alzheimer’s Death Rates ,By Age; 2006-2013


5

(c) AZOTH Analytics

List of Figures


Figure 16: Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients InMillion) 2010-2020F

Figure 17: Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014

Figure 18: Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients InMillion), By Region 2014

Figure 19: Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country2015E,2030F,2050F

Figure 20: Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014

Figure 21: Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million)2010-2020F

Figure 22: Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million)2010-2020F

Figure 23: Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million)2010-2020F

Figure 24: Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F

Figure 25: Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F

Figure 26: UK Dementia Market, By Type, 2014 (%)

Figure 27: UK Dementia Cost, By Type of Service, 2014 (%)

Figure 28: Number of Unpaid Caregivers (In Million)

Figure 29: Pfizer Revenue (USD Million) AY 2011-2014

Figure 30: Pfizer Percentage Revenue, By Business Segment (2014)

Figure 31: Pfizer Percentage Revenue, By Geography (2014)

6

(c) AZOTH Analytics

List of Figures


Figure 32: Novartis International AG Revenue (USD Million) AY 2011-2014

Figure 33: Novartis International AG Percentage Revenue, By Business Segment (2014)

Figure 34: Novartis International AG Percentage Revenue, By Geography (2014)

Figure 35: Axovant Services Ltd. Revenue (USD Million) FY 2011-2015

Figure 36: Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)

Figure 37: Axovant Services Ltd. Percentage Revenue, By Geography (2014)

Figure 38: Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014

Figure 39: Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)

Figure 40: Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)

Figure 41: Biotie Therapies Revenue (USD Million) AY 2011-2014

Figure 42: Biotie Therapies Percentage Revenue, By Business Segment (2014)

Figure 43: Sales Comparatives, Top 5 Companies, 2011-2014

Figure 44: EBITDA Comparatives, Top 5 Companies, 2011-2015

Figure 45: EBIT Comparatives, Top 5 Companies, 2011-2015

Figure 46: PBT Comparatives, Top 5 Companies, 2011-2015

Figure 47: PAT Comparatives, Top 5 Companies, 2011-2015

Figure 48: Current Ratio Comparatives, Top 5 Companies, 2011-2015

Figure 49: Profit Margin Ratio Comparatives, Top 5 Companies, 2011-2015

Figure 50: Debt Equity Ratio Comparatives, Top 5 Companies, 2011-2015

7

(c) AZOTH Analytics

Research Methodology

Research Definition

•Global Alzheimer’s disease Market Report comprises of the study of various aspects of Alzheimer’s Market and

forecast until 2020. The Alzheimer Disease Market has been segmented on basis of type of disease and type of

medical ailment and on regional basis globally.

Data Analysis and Interpretation

•Our historic market trend has been figured out by various paid databases which was further triangulated with various

secondary research sources along with primary interviews with the industry professionals/experts. Back-of-the-

Envelope calculation for the market estimation has been made through proper understanding of the market as well

as future business strategies of the companies involved in the market.

Azoth Analytics has conducted quantitative as well as qualitative research to gather market insights such as market sizing, market

segmentation, recent trends and developments and competitive landscape. Our team has conducted extensive primary surveys by

reaching out industry experts across the Alzheimer’s disease market.

For Forecasting purposes, we have accessed some of the paid databases such as Bloomberg, Reuters, Factiva, and Hoovers.

Companies ContactedPfizer Inc., Novartis International AG, Axovant Sciences Ltd.,Acadia Pharmaceuticals, Biotie Therapies

8

(c) AZOTH Analytics

Alzheimer’s Disease Market Overview

9

xxxx

xx xx xx xx xx xx xx xx xx xxxx xx xx xx xx xx xx xx xx xx xx xx

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Market Value Number of Patients

Figure 1: Global Alzheimer’s Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in

Million) 2010-2020F

xxxx

xxxx

xx xxxx xx

xxxx xx

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Figure 2: Global Alzheimer’s Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F

(c) AZOTH Analytics


10

xx

xxxx

xx

Disease Modifying

Therapeutics

Diagonistics and Bio

Markers

Imaging Sector

Therapeutics for

treatment of symtoms

Figure 3: Global Alzheimer’s Market share, By

Therapeutics

xx xx xx xx xx xx xx xx xx xx xx

2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020

Figure 9: Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of

Patients in Million) 2010-2020F

xx

xxxx

xx

xx

Asia Pacific America's Europe Africa Row

Figure 3: Global Alzheimer’s Market share, By Region,

2014(In %)

(c) AZOTH Analytics


11

xxxx

xxxx

xxxx

xxxx

xxxx

xxxx

xxxx

xx

xxxx

xxxx

xx

0%

2%

4%

6%

8%

10%

12%

14%

2010 2011 2012 2013 2014

Medicare Medicade Out of Pocket Other

Figure 11: Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14

xx xx xxxx xx xx xx xx xx Xx

0.00

10.00

20.00

30.00

40.00

50.00

60.00


(c) AZOTH Analytics


12

xxxx

xx xx xx xx xx xx xx xx xxxx xx xx xx xx xx xx xx xx xx xx

2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Number of Patients Value of the market

Figure 17: Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In

Million) 2010-2020F

xxxx

xxxx

Asia

Pacific

Europe The

America's

Africa

Figure 17: Global Dementia Disease Market Size , By

Volume (Number of Patients In Million), By Region

2014

xxxx

xxxx

Asia

Pacific

Europe The

America's

Africa

Figure 18: Global Dementia Disease Market Size , By

Number of new cases, By Volume (Number of Patients

In Million), By Region 2014

(c) AZOTH Analytics


13


2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Figure 22: Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million)

2010-2020F


2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F

Figure 22: Global Dementia Disease Market Size High Income Countries ,Volume (Number of Patients In Million)

2010-2020F

(c) AZOTH Analytics


14

xxxx xx xx

xx xx xx xx xx xx

China US India Japan Brazil Germany Russia Italy Indonesia France

Figure 23: Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million)

2010-2020F

xxxx

xx xx xx xx xx xx xx xx xx

2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F

Figure 24: Australia Dementia Disease Market Size , By Volume

(Number of Patients In Million) 2010-2020F

Alzheimer's

Disease

Vascular

Dementia

Mixed

Dementia

Dementia

with Lewy

BodiesFrontotemp

oral

DementiaSource: Azoth Analytics

Figure 26: UK Dementia Market, By

Type, 2014 (%)

(c) AZOTH Analytics

Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020)

(By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)

Number of Pages: 106

Price: US$ 2000 (Single User)

Price: US$ 3000 (Multi-User)

Order Online:

http://www.azothanalytics.com/report/global-alzheimer%E2%80%99s-drug-market-trends-opportunities-and-forecasts-2015-2020-r4

Contact Details

Contact Person: Subhodeep Sen

E-mail: [email protected]

Phone Number: Tel: +91 120 429 8235

24/7 Helpline Number: +91 9873 4262 88

About Azoth Analytics Pvt Ltd.

Our business research and market analysis helps organizations across different industry verticals solve their business problems. In our

reports, historic market trend is figured out by various paid databases which is further triangulated with inputs and insights from industry

experts through primary research. Back-of-the-Envelope calculation for the market estimation is being made through proper

understanding of the market as well as future business strategies of the companies engaged in the market. Our detailed research reports

help our clients and customers get clear understanding of a specific industry or vertical of a designated country or region and make

informed decision pertaining to market entry or expansion, strategic alliances or partnerships, product launch or brand positioning.

15

http://www.azothanalytics.com/report/global-alzheimer%E2%80%99s-drug-market-trends-opportunities-and-forecasts-2015-2020-r4

brochure-global alzheimers drug market trends opportunities and forecasts (2015-2020f)

Documents